Returning individual research results: development of a cancer genetics education and risk communication protocol
- PMID: 20831418
- PMCID: PMC3159194
- DOI: 10.1525/jer.2010.5.3.17
Returning individual research results: development of a cancer genetics education and risk communication protocol
Abstract
The obligations of researchers to disclose clinically and/or personally significant individual research results are highly debated, but few empirical studies have addressed this topic. We describe the development of a protocol for returning research results to participants at one site of a multicenter study of the genetic epidemiology of melanoma. Protocol development involved numerous challenges: (1) deciding whether genotype results merited disclosure; (2) achieving an appropriate format for communicating results; (3) developing education materials; (4) deciding whether to retest samples for additional laboratory validation; (5) identifying and notifying selected participants; and (6) assessing the impact of disclosure. Our experience suggests potential obstacles depending on researcher resources and the design of the parent study, but offers a process by which researchers can responsibly return individual study results and evaluate the impact of disclosure.
Figures
Similar articles
-
Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):522-9. doi: 10.1158/1055-9965.EPI-10-1045. Epub 2011 Feb 9. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21307304 Free PMC article.
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11. J Clin Oncol. 2003. PMID: 12692171
-
Navigating the Intersection between Genomic Research and Clinical Practice.Cancer Prev Res (Phila). 2020 Mar;13(3):219-222. doi: 10.1158/1940-6207.CAPR-19-0267. Cancer Prev Res (Phila). 2020. PMID: 32132115 Free PMC article. Review.
-
Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.Genet Med. 2019 Mar;21(3):727-735. doi: 10.1038/s41436-018-0093-6. Epub 2018 Jul 6. Genet Med. 2019. PMID: 29976988 Free PMC article.
-
Genetic epidemiology of cutaneous melanoma: a global perspective.Arch Dermatol. 2001 Nov;137(11):1493-6. doi: 10.1001/archderm.137.11.1493. Arch Dermatol. 2001. PMID: 11708953 Review. No abstract available.
Cited by
-
Biobank participants' preferences for disclosure of genetic research results: perspectives from the OurGenes, OurHealth, OurCommunity project.Mayo Clin Proc. 2014 Jun;89(6):738-46. doi: 10.1016/j.mayocp.2014.03.015. Mayo Clin Proc. 2014. PMID: 24943692 Free PMC article.
-
Using community-based participatory research principles to develop more understandable recruitment and informed consent documents in genomic research.PLoS One. 2015 May 4;10(5):e0125466. doi: 10.1371/journal.pone.0125466. eCollection 2015. PLoS One. 2015. PMID: 25938669 Free PMC article.
-
Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance.J Med Ethics. 2012 Jul;38(7):417-22. doi: 10.1136/medethics-2011-100273. Epub 2012 Mar 5. J Med Ethics. 2012. PMID: 22361295 Free PMC article.
-
Precision medicine in pediatric oncology: Lessons learned and next steps.Pediatr Blood Cancer. 2017 Mar;64(3):10.1002/pbc.26288. doi: 10.1002/pbc.26288. Epub 2016 Oct 17. Pediatr Blood Cancer. 2017. PMID: 27748023 Free PMC article. Review.
-
Reporting actionable research results: shared secrets can save lives.Sci Transl Med. 2012 Jul 18;4(143):143cm8. doi: 10.1126/scitranslmed.3003958. Sci Transl Med. 2012. PMID: 22814848 Free PMC article.
References
-
- Banks TM. Misusing informed consent: A critique of limitations on research subjects’ access to genetic research results. Saskatchewan Law Review. 2000;63(2):539–580. - PubMed
-
- Baumanis L, Evans JP, Callanan N, Susswein LR. Telephoned BRCA1/2 genetic test results: Prevalence, practice, and patient satisfaction. Journal of Genetic Counseling. 2009;18(5):447–463. - PubMed
-
- Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, et al. A design for cancer case-control studies using only incident cases: Experience with the GEM study of melanoma. International Journal of Epidemiology. 2006;35(3):756–764. - PubMed
-
- Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. Journal of the National Cancer Institute. 2005;97(20):1507–1515. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical